EtDO-P4 |
Catalog No.GC69085 |
EtDO-P4 es un inhibidor de síntesis de glucolípidos (GSL) a nivel nanomolar. EtDO-P4 inhibe la vía ERK inducida por EGFR y la activación de varios receptores tirosina quinasa (RTK). EtDO-P4 se puede utilizar en la investigación de diversos tipos de tumores, incluyendo el linfoma de Burkitt.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 245329-78-6
Sample solution is provided at 25 µL, 10mM.
Review for EtDO-P4
Average Rating: 5
(Based on Reviews and 30 reference(s) in Google Scholar.)Review for EtDO-P4
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *